Literature DB >> 9554629

Community respiratory viral infection in adult lung transplant recipients.

S M Palmer1, N G Henshaw, D N Howell, S E Miller, R D Davis, V F Tapson.   

Abstract

STUDY
OBJECTIVE: To define the epidemiology, clinical manifestations, and long-term complications of respiratory viral infections in adult lung transplant recipients.
DESIGN: Retrospective review of the records of 122 adult lung transplant recipients over a 5-year period at one institution.
RESULTS: Ten episodes of infection with respiratory syncytial virus, parainfluenza, influenza, or adenovirus were identified. All patients presented with symptoms of respiratory tract infection. Two patients died acutely and four patients subsequently had development of obliterative bronchiolitis (OB).
CONCLUSIONS: These data suggest community respiratory viral infections cause significant morbidity and mortality in lung transplant recipients. Further prospective studies are warranted to clarify the relationship between respiratory viral infection and OB and to define the optimal therapy for these viral infections.

Entities:  

Mesh:

Year:  1998        PMID: 9554629     DOI: 10.1378/chest.113.4.944

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

1.  Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation.

Authors:  Lewis H McCurdy; Barney S Graham
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 2.  Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.

Authors:  Andrew I R Scott; Linda D Sharples; Susan Stewart
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

Review 4.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

5.  Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.

Authors:  Kari Neemann; Alison Freifeld
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

Review 6.  Viral prophylaxis in organ transplant patients.

Authors:  Michelle Slifkin; Shira Doron; David R Snydman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Chronic lung allograft dysfunction.

Authors:  Anupam Kumar; Puneet Singh Garcha
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-11-16

8.  The Use of Aerosolized Ribavirin in Respiratory Syncytial Virus Lower Respiratory Tract Infections in Adult Immunocompromised Patients: A Systematic Review.

Authors:  Lisa Avery; Charles Hoffmann; Karen M Whalen
Journal:  Hosp Pharm       Date:  2019-03-27

9.  Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.

Authors:  Andres Pelaez; G Marshall Lyon; Seth D Force; Allan M Ramirez; David C Neujahr; Marianne Foster; Priyumvada M Naik; Anthony A Gal; Patrick O Mitchell; E Clinton Lawrence
Journal:  J Heart Lung Transplant       Date:  2009-01       Impact factor: 10.247

10.  Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies.

Authors:  Auke de Zwart; Annelies Riezebos-Brilman; Gerton Lunter; Judith Vonk; Allan R Glanville; Jens Gottlieb; Nitipong Permpalung; Huib Kerstjens; Jan-Willem Alffenaar; Erik Verschuuren
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.